{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/819483525",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1800910986"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1920865714",
    "http://id.who.int/icd/release/11/2024-01/mms/251423292",
    "http://id.who.int/icd/release/11/2024-01/mms/1628295315",
    "http://id.who.int/icd/release/11/2024-01/mms/559507460",
    "http://id.who.int/icd/release/11/2024-01/mms/1319686829",
    "http://id.who.int/icd/release/11/2024-01/mms/819483525/other",
    "http://id.who.int/icd/release/11/2024-01/mms/819483525/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#819483525",
  "code": "KA8A",
  "source": "http://id.who.int/icd/entity/819483525",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Polycythaemia neonatorum"
  },
  "definition": {
    "@language": "en",
    "@value": "Polycythaemia of the neonate represents an excessive quality of circulating red blood cells due to excessive marrow production and haematocrits that exceed ~60%."
  },
  "longDefinition": {
    "@language": "en",
    "@value": "Polycythemia of the neonate represents an excessive qualtity of circulating red blood cells due to excessive marrow production and hematocrits that exceed ~60%. Polycythemia can or cannot be associated with hyperviscosity and may or may not be symptomatic."
  }
}